A Study of Emapalumab for Pediatric Aplastic Anemia
A Study of Emapalumab for Pediatric Aplastic Anemia
Recruiting · NCT06430788 · Registry updated 2025-12-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Emapalumab for Pediatric Aplastic Anemia | Bone Marrow Failure Disorders, Cytopenia, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorder | Recruiting | Phase 2 | 2025-12-17 | NCT06430788 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital of Philadelphia (Data Collection AND Specimen Analysis) | Philadelphia | United States | 1 |
| Children's Hospital of Wisconsin (Data Collection Only) | Milwaukee | United States | 1 |
| Cincinnati Children's Hospital Medical Center (Data Collection Only) | Cincinnati | United States | 4 |
| Medical College of Wisconsin (Data Collection AND Data Analysis) | Milwaukee | United States | 1 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |
| Virginia Commonwealth University (Data Collection Only ) | Richmond | United States | 1 |